Russian Coronavirus vaccine: 1 in 7 people reporting side-effects from Sputnik vaccine.

  • 8Russia’s COVID-19 vaccine, Sputnik V is coming to India.

As per the latest developments, Russia’s first registered vaccine, Sputnik V will be tested and distributed in India after officials from both the countries signed a strategic deal to ensure priority access.
Reports suggest that Hyderabad-based Dr Reddy’s Laboratories will be in charge of conducting phase III trials in India, post which, the DGCI will be granting authorisation for the vaccine to be distributed for the public, which could be as early as early December. At least 100 million doses will be exclusively reserved for India, whose recent COVID-19 case trajectory is only pressing dire hopes for a vaccine to be ready soon.

  • 8Is Sputnik V safer than Oxford-Astrazeneca vaccine?

While on one hand, the availability of Sputnik V makes getting our hands on a vaccine easier, it is still unsure whether or not the vaccine would be the safest, most effective or work across age groups- especially in a demographically diverse country like India. Fresher reports emerging out of Russia have only clouded the judgement further.


New reports to come out of clinical studies have found that 1 in 7 people suffered from side-effects post being inoculated by the Russian vaccine. The Soviet nation’s health minister, Mikhail Murashko, in a statement to Moscow Times said that nearly 14% of patients who have been administrated the vaccine reported suffering from side-effects.

  • 814% of volunteers reported side-effects.

New reports to come out of clinical studies have found that 1 in 7 people suffered from side-effects post being inoculated by the Russian vaccine. The Soviet nation’s health minister, Mikhail Murashko, in a statement to Moscow Times said that nearly 14% of patients who have been administrated the vaccine reported suffering from side-effects.


However, terming the side-effects to be mild and routine, Murashko still said that the Russian vaccine is still safer and at-par with global competitors.

“Approximately 14 per cent have small complaints of weakness, muscle pain for 24 hours and an occasional increase in body temperature,”
Terming these effects to be normal, the minister also said that the symptoms were ‘level off’ by the next day and they would keep tracking vitals to notice adversities if any